Verona Pharma plc (NASDAQ: VRNA) reported Q1 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $76.3 million versus the consensus estimate of $52.7 million.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.